Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Short term Debt: 2015-2019

Historic Short term Debt for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $6.7 million.

  • Outlook Therapeutics' Short term Debt rose 9976.71% to $6.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.7 million, marking a year-over-year increase of 9976.71%. This contributed to the annual value of $6.7 million for FY2019, which is 9976.71% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Short term Debt of $6.7 million as of FY2019, which was up 9,976.71% from $66,480 recorded in FY2018.
  • Outlook Therapeutics' 5-year Short term Debt high stood at $6.7 million for FY2019, and its period low was $52,600 during FY2017.
  • Its 3-year average for Short term Debt is $2.3 million, with a median of $66,480 in 2018.
  • Per our database at Business Quant, Outlook Therapeutics' Short term Debt tumbled by 91.03% in 2017 and then spiked by 9,976.71% in 2019.
  • Outlook Therapeutics' Short term Debt (Yearly) stood at $742,646 in 2015, then dropped by 21.03% to $586,454 in 2016, then tumbled by 91.03% to $52,600 in 2017, then climbed by 26.39% to $66,480 in 2018, then spiked by 9,976.71% to $6.7 million in 2019.